The company has developed a diagnostic/prognostic kit for B-cell leukaemia. The kit can diagnose B-cell leukaemia and make a prognosis for the expected future course of the disease for the patient.

The kit has been developed so it can be adapted to the analysis equipment which is used at the hospitals’ central analysis laboratories.

The company was founded in December 2006.